Xilio Therapeutics, Inc. (XLO)
NASDAQ: XLO · Real-Time Price · USD
8.01
+0.70 (9.58%)
At close: Oct 27, 2026, 4:00 PM EDT
8.00
-0.01 (-0.12%)
After-hours: Oct 27, 2026, 7:30 PM EDT
Xilio Therapeutics Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Xilio Therapeutics stock has a consensus rating of "Buy" and an average price target of $18. The average 1-year stock price forecast is 124.72% higher than the current stock price, while the lowest is $16 (+99.75%) and the highest is $20 (+149.69%).
Price Target: $18 (+124.72%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Xilio Therapeutics stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Nov '25 | Dec '25 | Mar '26 | May '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 1 | 1 | 1 | 1 | 2 |
Financial Forecast
Revenue This Year
40.17M
from 43.77M
Decreased by -8.23%
Revenue Next Year
49.77M
from 40.17M
Increased by 23.90%
EPS This Year
-7.84
EPS Next Year
-27.72
from -7.84
EPS and Forward PE are based on non-GAAP adjusted numbers.